Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America

undefined; Humberto Martínez-Cordero; Camila Peña; Natalia Paola Schutz; Virginia Bove; Fiorella Villano; Cecilia Beltran; Javiera Donoso; Hernán López-Vidal; Macarena Alejandra Roa Salinas; Pablo Soto; Paola Ochoa; Patricio Duarte; Guillermina Remaggi; Ariel Corzo; Claudia Shanley; Sergio Lopresti; Sergio Orlando; Verónica Verri; Luis Darío Quiroga; Dorotea Fantl; Jhoanna Ramirez; Alejandro Ospina-Idárraga; Henry Idrobo; Guillermo Quintero; Rigoberto Gomez; Omar Cantú-Martínez; David Gomez-Almaguer; Guillermo J. Ruiz-Arguelles; Kenny Mauricio Galvez-Cárdenas; Luis Antonio Salazar; Isabella Novoa-Caicedo; María Cynthia Fuentes-Lacouture; Paola Spirko; María Isabel Arbeláez; Mario Pereira; Jaime Valdes; Jule Vasquez; Alana von Glasenapp; Eloísa Riva

Journal ArticleOPEN ACCESS

Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America

Martínez-Cordero H
Peña C
et al.

JCO Global Oncology (2023) (9)

DOI: 10.1200/go.23.00182

7Citations

11Readers

Abstract

Outcomes of Multiple myeloma patients aged 40 years and younger in LATAM

Cite

CITATION STYLE

APA

Martínez-Cordero, H., Peña, C., Schutz, N. P., Bove, V., Villano, F., … Riva, E. (2023). Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients’ Evidence From Latin America. JCO Global Oncology, (9). https://doi.org/10.1200/go.23.00182

Patients Age 40 Years and Younger With Multiple Myeloma Have the Same Prognosis as Older Patients: An Analysis of Real-World Patients' Evidence From Latin America

Abstract

Cite

Register to see more suggestions